KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -177.5% | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.3% | +1.3% | +2.4% | +7.8% | +3.4% | +6.3% | +2,738.6% | -98.0% | -3.9% | +11.6% | +0.7% | -7.1% | +0.4% | -0.4% | -0.4% | -3.1% | – | – | -22.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -104.2% | – | – | – | – | -148.2% | – | – | – | – | – | |
| – | -75.2% | -21.1% | +7.8% | +5.1% | +118.3% | +46.4% | -10.8% | +0.2% | +26.8% | +16.8% | +2.2% | +5.0% | +0.3% | -4.1% | +15.5% | -1.7% | +14.4% | +0.6% | +12.7% | -7.1% | +11.9% | +3.7% | +22.2% | +7.2% | +23.3% | +14.6% | +13.0% | -4.6% | -24.2% | -5.1% | -0.3% | -1.3% | -24.0% | -21.3% | -27.9% | -26.5% | -69.6% | – | |
| – | -95.2% | +2.3% | +45.6% | +23.3% | +93.4% | +13.7% | -7.1% | +9.6% | +35.9% | +2.0% | +7.0% | -1.3% | +17.7% | -10.5% | +21.7% | -10.4% | +27.5% | -2.5% | +8.3% | +8.8% | +14.2% | +0.9% | +1.8% | +2.1% | +19.9% | -6.8% | +51.9% | -37.6% | +19.3% | -14.3% | +1.8% | -2.8% | -1.7% | -7.9% | -4.3% | -32.3% | +60.3% | – | |
| – | -74.9% | -16.7% | +16.5% | +10.4% | +110.3% | +36.6% | -9.9% | +2.6% | +29.3% | +12.6% | +3.5% | +3.3% | +4.8% | -6.0% | +17.2% | -4.2% | +17.9% | -0.3% | +11.5% | -2.7% | +12.6% | +2.8% | +16.0% | +5.8% | +22.4% | +9.2% | +20.4% | -12.8% | -16.6% | -0.3% | -6.1% | -1.8% | -18.2% | -17.2% | -19.8% | -30.4% | -9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +243.4% | -100.0% | – | -4.5% | -16.3% | – | – | -24.2% | -25.8% | -51.5% | -57.5% | -13.0% | -21.3% | +329.7% | +59.7% | +7.1% | +14.0% | +12.6% | +6.0% | +4.1% | +2.9% | +0.8% | +0.3% | +0.2% | +0.5% | -3.5% | -10.8% | -13.0% | +78.1% | -66.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +179.5% | -364.7% | – | – | – | -109.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.